Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma

Antibodies targeting CD38 are rapidly changing the treatment landscape of multiple myeloma (MM). CD38−directed antibodies have several mechanisms of action. Fc−dependent immune effector mechanisms include complement-dependent cytotoxicity (CDC), antibody−dependent cell−mediated cytotoxicity (ADCC),...

Descripción completa

Detalles Bibliográficos
Autores principales: Franssen, Laurens E., Stege, Claudia A. M., Zweegman, Sonja, van de Donk, Niels W. C. J., Nijhof, Inger S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230744/
https://www.ncbi.nlm.nih.gov/pubmed/32331242
http://dx.doi.org/10.3390/jcm9041195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230744/
https://www.ncbi.nlm.nih.gov/pubmed/32331242
http://dx.doi.org/10.3390/jcm9041195

Ejemplares similares